Miami International Holdings, Inc. (MIAX)
Live price chart, market sentiment, and community perspectives for Miami International Holdings, Inc. (NYSE: MIAX).
Live price chart, market sentiment, and community perspectives for Miami International Holdings, Inc. (NYSE: MIAX).
On our desk, the consensus around MIAX is leaning increasingly constructive following their stellar Q1 print. Seeing net revenue grow 40% year-over-year while adjusted EBITDA margins expanded by 800 basis points to 51% proves their scaling model is finally hitting optimal leverage. The Street is taking notice, with Keefe, Bruyette and Woods nudging their target up to $48. That said, trading at a trailing P/E of roughly 30x means you are paying a fair growth multiple. If volume spikes sustain through the back half of the year, the current $52 average consensus target looks entirely defensible.
Looking closely at the July 2026 trading metrics, you have to parse the core options strength away from the volatility in their futures verticals. While the MIAX Exchange Group set a record YTD average daily volume of 10.9 million contracts—up over 26%—certain segments like financial futures ADV saw sharp double-digit contractions month-over-month. As a quantitative risk analyst, I note that while options liquidity and market share gains are stable, reliance on high market volatility as a volume catalyst introduces pipeline lumpiness that retail investors often overlook.
When evaluating potential strategic candidates or underwriting positions in exchange operators like MIAX, technical due diligence needs to focus heavily on asset diversification. Their integration of Dorman Trading and expansion into diverse assets—from equities and multi-listed options to the Bermuda Stock Exchange—provides structural revenue defense. However, candidates must thoroughly understand how balance sheet items, such as locked token valuations (e.g., Pyth Network tokens) and asset sales, impact non-operating adjustments in quarterly earnings reports.
Explore plasma cleansing, somatic organ swaps, and BCI.